These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [The therapeutic problem of arteriosclerotic arteriopathies of the lower extremities]. Gatta L; Montemurro G Minerva Med; 1980 Apr; 71(16):1173-9. PubMed ID: 7375035 [No Abstract] [Full Text] [Related]
24. [Use of allikor for the normalization of fibrinolysis and hemostasis in patients with chronic cerebrovascular diseases]. Andrianova IV; Ionova VG; Demina EG; Shabalina AA; Karabasova IaA; Liutova LI; Povorinskaia TE; Orekhov AN Klin Med (Mosk); 2001; 79(11):55-8. PubMed ID: 11811113 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of patients with initial manifestations of cerebrovascular insufficiency in atherosclerosis]. Kanareĭkin KF; Manvelov LS; Shvedkov VV Klin Med (Mosk); 1994; 72(1):56-60. PubMed ID: 8196329 [No Abstract] [Full Text] [Related]
27. [Effect of various drugs on the dynamics of fibrinolysis in humans]. Brunetti S; Tesi M Riv Crit Clin Med; 1967 Aug; 67(3):233-45. PubMed ID: 5633715 [No Abstract] [Full Text] [Related]
29. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Viles-Gonzalez JF; Fuster V; Badimon JJ Eur Heart J; 2004 Jul; 25(14):1197-207. PubMed ID: 15246637 [TBL] [Abstract][Full Text] [Related]
30. [Fibrinolytic therapy of arteriosclerosis. Influence on hemocoagulation of a total arterial wall extract for oral use]. Guglielmi G; Barlattani M; Garbagnati N; Iaschi P; Ciavarelli F Clin Ter; 1969 Sep; 50(6):527-36. PubMed ID: 5406050 [No Abstract] [Full Text] [Related]
32. [Atherothrombosis: state-of-the-art review and approaches to the problem]. Bokarev IN; Popova LV Klin Med (Mosk); 2008; 86(8):4-12. PubMed ID: 18819339 [TBL] [Abstract][Full Text] [Related]
33. [New agents and challenges in the antithrombotic management of arterial diseases]. Udvardy M; Rák K Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617 [TBL] [Abstract][Full Text] [Related]
34. [Antithrombotic agents and cerebrovascular prevention: what is new?]. Bogousslavsky J Schweiz Med Wochenschr; 1997 Nov; 127(47):1941-4. PubMed ID: 9480533 [No Abstract] [Full Text] [Related]
36. [The treatment and outlook of atherosclerosis today]. Faggiotto A; Paoletti R Ital Heart J Suppl; 2000 Jan; 1(1):30-7. PubMed ID: 10832118 [TBL] [Abstract][Full Text] [Related]
37. [Effect of pyridinol carbamate on long-term lathyrism and experimental atheroma in the rat. Histological and biochemical study]. Bouissou H; de Graeve J; Julian M; Pieraggi MT; Thiers JC Paroi Arterielle; 1980; 6(1):3-15. PubMed ID: 7422355 [TBL] [Abstract][Full Text] [Related]
38. Antithrombotic therapy for prevention of recurrent stroke in the new millennium. Schneck MJ; Biller J Expert Rev Neurother; 2004 Mar; 4(2):145-9. PubMed ID: 15853554 [No Abstract] [Full Text] [Related]
39. [L-triiodothyronine in the prevention and therapy of arteriosclerosis]. Pompei A; Traverso E; Ronzitti M Arch Maragliano Patol Clin; 1969; 25(6):519-36. PubMed ID: 5409098 [No Abstract] [Full Text] [Related]